Tham khảo 3,4-Methylenedioxyamphetamine

  1. ↑ Crean, R. D.; Davis, S. A.; Von Huben, S. N.; Lay, C. C.; Katner, S. N.; Taffe, M. A. (ngày 13 tháng 10 năm 2006). “Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques”. Neuroscience 142 (2): 515–525. PMC 1853374. PMID 16876329. doi:10.1016/j.neuroscience.2006.06.033. 
  2. 1 2 de la Torre, R; Farre, M; Roset, Pn; Pizzaro, N; Abanades, S; Segura, M; Segura, M; Camí, J (2004). “Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.”. Therapeutic Drug Monitoring 26: 137–144. PMID 15228154. doi:10.1097/00007691-200404000-00009. 
  3. ↑ EcstasyData.org. “EcstasyData.org: Test Result Statistics: Substances by Year”. www.ecstasydata.org. Truy cập ngày 27 tháng 6 năm 2017. 
  4. ↑ “Trans European Drug Information”. idpc.net (bằng tiếng Anh). Truy cập ngày 27 tháng 6 năm 2017. 
  5. ↑ Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (1993). “Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine”. Journal of Medicinal Chemistry 36 (23): 3700–3706. PMID 8246240. doi:10.1021/jm00075a027. 
  6. 1 2 3 Baggott, MJ; Siegrist, JD; Galloway, GP; Robertson, LC; Coyle, JR; Mendelson, JE. “Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxeamphetamine (MDA): A Randomized Controlled Trial in Humans”. PLOS ONE 5: e14074. PMC 2996283. PMID 21152030. doi:10.1371/journal.pone.0014074. 
  7. 1 2 Herndon, Joseph M.; Cholanians, Aram B.; Lau, Serrine S.; Monks, Terrence J. (tháng 3 năm 2014). “Glial Cell Response to 3,4-(±)-Methylenedioxymethamphetamine and Its Metabolites”. Toxicological Sciences 138 (1): 130–138. ISSN 1096-6080. PMC 3930364. PMID 24299738. doi:10.1093/toxsci/kft275. 
  8. ↑ Kalant, Harold (ngày 2 tháng 10 năm 2001). “The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs”. CMAJ: Canadian Medical Association Journal 165 (7): 917–928. ISSN 0820-3946. PMC 81503. PMID 11599334. 
  9. ↑ Diaz, Jaime. How Drugs Influence Behavior. Englewood Cliffs: Prentice Hall, 1996.
  10. ↑ Lewin AH, Miller GM, Gilmour B (tháng 12 năm 2011). “Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class”. Bioorg. Med. Chem. 19 (23): 7044–8. PMC 3236098. PMID 22037049. doi:10.1016/j.bmc.2011.10.007. 
  11. ↑ Rothman RB, Baumann MH (2006). “Therapeutic potential of monoamine transporter substrates”. Curr Top Med Chem 6 (17): 1845–59. PMID 17017961. doi:10.2174/156802606778249766. 
  12. ↑ Giuseppe Di Giovanni; Vincenzo Di Matteo; Ennio Esposito (2008). Serotonin-dopamine Interaction: Experimental Evidence and Therapeutic Relevance. Elsevier. tr. 294–. ISBN 978-0-444-53235-0. 
  13. ↑ Rothman, Richard B; Baumann, Michael H (2009). “Serotonergic drugs and valvular heart disease”. Expert Opinion on Drug Safety 8 (3): 317–329. ISSN 1474-0338. PMC 2695569. PMID 19505264. doi:10.1517/14740330902931524. 
  14. ↑ Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA (1994). “Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors”. Neurosci. Lett. 177 (1–2): 111–5. PMID 7824160. doi:10.1016/0304-3940(94)90057-4. 
  15. ↑ Manzoni, Olivier Jacques; Ray, Thomas S. (2010). “Psychedelics and the Human Receptorome”. PLoS ONE 5 (2): e9019. ISSN 1932-6203. PMC 2814854. PMID 20126400. doi:10.1371/journal.pone.0009019. 
  16. ↑ Muszynski, I.E. (1961). “Production of some amphetamine derivatives”. Acta poloniae pharmaceutica 18: 471–478. PMID 14477621. 
  17. 1 2 3 Shulgin, Alexander; Manning, Tania; Daley, Paul (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds (ấn bản 1). Berkeley, CA: Transform Press. tr. 165. ISBN 9780963009630. 
  18. ↑ Noggle, FT Jr; DeRuiter, J.; Long, MJ. (1986). “Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs”. Journal Association of Official Analytical Chemists 69 (4): 681–686. PMID 2875058. 
  19. ↑ Mannich, C.; Jacobsohn, W.; Mannich, Hr. C. (1910). “Über Oxyphenyl-alkylamine und Dioxyphenyl-alkylamine”. Berichte der deutschen chemischen Gesellschaft 41 (1): 189–197. doi:10.1002/cber.19100430126. 
  20. ↑ Ho, Beng-Thong; McIsaac, William M.; An, Rong; Tansey, L. Wayne; Walker, Kenneth E.; Englert Jr., Leo F.; Noel, Michael B. (1970). “Analogs of a-methylphenethylamine”. Journal of Medicinal Chemistry 13 (1): 26–30. PMID 5412110. doi:10.1021/jm00295a007. 
  21. ↑ Butterick, John R.; Unrau, A. M. (1974). “Reduction of β-nitrostyrene with sodium bis-(2-methoxyethoxy)-aluminium dihydride. A convenient route to substituted phenylisopropylamines”. Journal of the Chemical Society, Chemical Communications 8 (8): 307–308. doi:10.1039/C39740000307. 
  22. ↑ Toshitaka, Ohshita; Hiroaka, Ando (1992). “Synthesis of Phenethylamine Derivatives as Hallucinogen”. Japanese Journal of Toxicology and Environmental Health 38 (6): 571–580. Truy cập ngày 20 tháng 6 năm 2014. 
  23. ↑ Shulgin, Alexander & Shulgin, Ann (1991). PiHKAL: A Chemical Love Story. Lafayette, CA: Transform Press. ISBN 9780963009609. 
  24. ↑ Elks, J.; Hey, D. H. (1943). “7. β-3: 4-Methylenedioxyphenylisopropylamine”. J. Chem. Soc. 0 (0): 15–16. ISSN 0368-1769. doi:10.1039/JR9430000015. 
  25. 1 2 Poisons Standard (October 2015) comlaw.gov.au

Tài liệu tham khảo

WikiPedia: 3,4-Methylenedioxyamphetamine http://www.chemspider.com/Chemical-Structure.1555.... http://www.eurekaselect.com/77046/article http://www.sciencedirect.com/science/article/pii/S... //www.ncbi.nlm.nih.gov/pmc/articles/PMC1853374 //www.ncbi.nlm.nih.gov/pmc/articles/PMC2695569 //www.ncbi.nlm.nih.gov/pmc/articles/PMC2814854 //www.ncbi.nlm.nih.gov/pmc/articles/PMC2996283 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3236098 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3930364 //www.ncbi.nlm.nih.gov/pmc/articles/PMC81503